Literature DB >> 6288331

Adrenocortical responsiveness to the synthetic ACTH 1-17 analogue given at different circadian stages.

E Ferrari, P A Bossolo, G P Carnevale Schianca, S B Solerte, M Fioravanti, M Nascimbene.   

Abstract

The study concerns the adrenocortical glucocorticoid responsiveness to the ACTH 1-17 analogue given at different times of the day, namely near to the zenith and the nadir of the circadian curve of plasma cortisol. Two schedules of administration of the heptadecapeptide have been performed: a pulse i.v. injection of 4 microgram; b. i.m. injection of 100 microgram. Both the doses were given to the same subject in the morning and in the evening of different days. The chrono-sensitivity of the adrenal cortex to ACTH 1.17 analogue is well evident after pulse stimulation by a micro-dose of the heptadecapeptide; in fact the plasma cortisol increase from basal values is significantly higher in evening than in the morning (p less than 0.001). The cortico-stimulatory effect of the higher dose of ACTH 1.17 analogue lasts about 12 h. and then plasma and urinary glucocorticoids take the usual circadian pattern again.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288331

Source DB:  PubMed          Journal:  Chronobiologia        ISSN: 0390-0037


  3 in total

1.  Acute administration of melatonin at two opposite circadian stages does not change responses to gonadotropin releasing hormone, thyrotropin releasing hormone and ACTH in healthy adult males.

Authors:  P Paccotti; M Terzolo; M Torta; A Vignani; M Schena; A Piovesan; A Angeli
Journal:  J Endocrinol Invest       Date:  1987-10       Impact factor: 4.256

2.  Circadian and seasonal changes in ACTH-induced effects in healthy young men.

Authors:  A Reinberg; Y Touitou; F Levi; A Nicolai
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Morning to evening changes of human pituitary and adrenal responses to specific stimuli.

Authors:  M Terzolo; A Piovesan; G Osella; B Puligheddu; M Torta; P Paccotti; A Angeli
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.